Melasma is a complex, acquired hyperpigmentation disorder that often affects individuals with dark-pigmented skin (Fitzpatrick skin phototypes III to VI), who have an increased tendency toward excessive melanin synthesis. The development of melasma is associated with a variety of intrinsic and extrinsic factors, the most prominent being prolonged exposure to UV radiation, hormonal influences, and genetic predisposition. As a chronic condition, melasma responds unpredictably to treatments aimed at reducing its appearance and frequently recurs, making it a significant challenge in both dermatological and cosmetic practice.
In this thesis, a systematic review of the current scientific literature was conducted using the PubMed® database. Clinical studies were analyzed that investigated the effectiveness of various instrumental methods for melasma management, with a focus on picosecond and pulsed lasers, as well as microneedling therapy. Particular emphasis was placed on the use of tranexamic acid in combination with instrumental procedures. The analysis encompassed three main areas: laser treatments without tranexamic acid, laser treatments with tranexamic acid, and microneedling combined with tranexamic acid. The results showed that laser procedures, especially the Q-switched Nd:YAG laser and the picosecond alexandrite laser, are often effective in the short-term reduction of melasma, although the long-term stability of results remains a challenge. The addition of tranexamic acid contributed, in several studies, to a faster initial improvement and a reduced recurrence rate of the condition. Microneedling therapy proved to be a safe and well-tolerated method, particularly suitable for darker skin phototypes. The analysis also revealed limitations of clinical studies, including small sample sizes, variability of treatment protocols, and a lack of long-term research. This thesis provides an overview of the most current approaches to melasma management.
|